Market Place
Sourcing Support
PatientSeek Finds Genetic Signature For IBD Therapy Response
16 Sep 2024 //
GLOBENEWSWIRE
C4X Discovery Reports On Programs And Appoints New Board Members
22 Jul 2024 //
GLOBENEWSWIRE
C4X sells substance disorder drug rights to Indivior for $20M
01 Aug 2023 //
FIERCE BIOTECH
C4X Discovery Holdings Announces Divestment of Orexin-1 to Indivior for £15.95m
01 Aug 2023 //
ACCESSWIRE
C4XD and Garvan Institute of Research report patient stratification approach
22 Feb 2023 //
GLOBENEWSWIRE
C4XD and AstraZeneca enter $402m deal to develop respiratory disease therapy
29 Nov 2022 //
PHARMACEUTICAL-TECHNOLOGY
C4X Discovery Receives Sanofi Milestone Payment
06 Jul 2022 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.